Difficulty: Medium
Average Score: 90%
Practice
A woman in the 28th week of pregnancy with pregnancy-induced hypertension (BP 150/95 mmHg) should receive
Correct answer
B
Rationale
In the case of a woman in the 28th week of pregnancy with pregnancy-induced hypertension (BP 150/95 mmHg), the most appropriate drug for her to receive is Methyldopa (Option B). Methyldopa is considered the first-line treatment for hypertension in pregnancy due to its proven safety profile for both the mother and the developing fetus. It is a centrally acting alpha-2 adrenergic agonist that helps lower blood pressure without negatively impacting the pregnancy.
Furosemide (Option A) is a diuretic that is contraindicated in pregnancy as it can lead to electrolyte imbalances and reduced placental perfusion, potentially harming the fetus.
Propranolol (Option C) is a beta-blocker that can cause fetal growth restriction, bradycardia, and hypoglycemia, making it unsuitable for use in pregnancy.
Captopril (Option D) is an ACE inhibitor that is contraindicated in pregnancy due to its association with fetal renal damage, hypotension, and even fetal death.
Educationally, this question highlights the importance of selecting appropriate medications for pregnant patients, considering not only the efficacy for the mother but also the safety for the developing fetus. It underscores the need for healthcare providers to have a solid understanding of pharmacology in pregnancy to make informed and safe treatment decisions.
Furosemide (Option A) is a diuretic that is contraindicated in pregnancy as it can lead to electrolyte imbalances and reduced placental perfusion, potentially harming the fetus.
Propranolol (Option C) is a beta-blocker that can cause fetal growth restriction, bradycardia, and hypoglycemia, making it unsuitable for use in pregnancy.
Captopril (Option D) is an ACE inhibitor that is contraindicated in pregnancy due to its association with fetal renal damage, hypotension, and even fetal death.
Educationally, this question highlights the importance of selecting appropriate medications for pregnant patients, considering not only the efficacy for the mother but also the safety for the developing fetus. It underscores the need for healthcare providers to have a solid understanding of pharmacology in pregnancy to make informed and safe treatment decisions.